The results of the research will be helpful to expand the knowledge on diseases related to the process of protein aggregation. Discovery of this might lead to the early detection of Alzheimer ’s disease. The research has found a way to precisely measure the effects that protein aggregation has on cell aging.
The prestigious medical journal ‘The Lancet’ publishes findings from Barcelona’s CRESIB researchers who work in Papua New Guinea. The study has found a an oral treatment for Pian’s disease, also known as Yaws. The treatment could lead to the total eradication of the illness.
The project’s aim is to design maritime platforms able to produce hydrogen, generated with the help of green energies. The platforms could be used to provide service to oil tankers or to fix even fish farming, among others potential uses.
Sant Joan de Déu Hospital in Greater Barcelona has become the first facility in the world to assist a woman who lost her two ovaries to get pregnant. A decade ago she had to have her ovaries completely removed because of two tumours. Ovarian tissue was frozen, kept for ten years and now re-implanted. The patient has had her period again and, thanks to in vitro fertilisation, is now pregnant.
Catalonia is fast becoming an international reference point in research projects thanks mainly to a large number of articles being produced and exchange initiatives with other countries being set up. Catalan research centres, especially medical and technical institutions, have accomplished an important level of international recognition after a relatively short period of time.
The Parkinson symptoms detector device will help patients fight the degenerative disease and improve their quality of life. The system, partly created by Catalan researchers, now needs to be tested on four volunteer patients from around Catalonia. The initiative has brought together institutions from Italy, Israel, Germany and Spain.
The brain damage a foetus may suffer during pregnancy is sometimes not detected in the first few years of a child's life. If that damage could be detected early, psychological stimulation could reduce future learning disorders. Scientists from Barcelona’s Hospital Clínic have identified biomarkers indicating possible brain damage while carrying out a brain scan.
The Spanish IT multinational company Intel and the Barcelona Supercomputing Center will create a joint research and development lab to calculate speeds on the exaFLOP scale, which are a thousand times quicker than the current fastest computers in the world. The lab will be created in Barcelona over the coming years, at the BSC facilities. Intel hopes to reach Exascale performance within the next ten years.
The last ‘SCImago Institutions Ranking’ classified the 3,000 best research institutions in the world. Harvard University tops the ranking, but the Catalan institute, is ranked second in Spain and among the best European research centres. Catalonia, and in particular Barcelona is consolidating its position as a biomedical science centre at international level.
For the first time in the world, a foetus having the spina bifida congenital disorder went through a new intra-uterus surgery technique. A medical team from Barcelona’s Vall d’Hebron Hospital operated on the foetus in its 24th week by placing a biological fabric on the spinal cord, in order to protect it from amniotic liquid and to ease the gap’s closing. The baby is now five months old and doctors are confident she may walk without any problems.
The vaccine MVA-B against HIV gets a 90% immune response in its first test with humans. In addition, after a year, the vaccine proves to still be effective in 85% of the individuals. The vaccine is still a prototype but it shows a promising perspective. Soon it will be tested as well as a therapeutic vaccine, for people already infected with HIV-AIDS. The vaccine has been developed by the Spanish High Council of Scientific Research (CSIC), in collaboration with Barcelona’s Hospital Clínic and by Madrid’s Hospital Gregorio Marañón.
Between 2007 and 2010, Catalan research centres and private companies participated in a total of 1,047 projects funded by the Seventh Framework Programmes for Research and Technological Development of the European Union. In total, Catalan researchers have received 384 million euros from the EU in the last four years, which represents a 73% increase in relation to the previous programme, which ran from mid 2002 to 2006.
The study by the Bellvitge Biomedical Research Institute has managed to demonstrate that a molecule similar to glucose can cause the death of cancerous cells. The research would enable to shortly develop treatments for the alveolar rhabdomyosarcoma.
"This could mean a breakthrough in the fight against cancer," said the head of the study Juan Angel Recio from Barcelona-based Vall d’Hebron Research Institute.
The research results were published on the website of the prestigious journal 'Nature Chemistry' and will appear in the print edition as well. The Universitat de Girona is particularly strong in research related to water. The study opens a new path to develop new technologies to carry out artificial photosynthesis.